LOGO
LOGO

Cancer

Space Station Research Yields Insights Into FDA-Approved Cancer Therapy

By Joji Xavier   ✉   | Published:   | Follow Us On Google News
spacestationcancer 08012026 lt

A research conducted at the International Space Station has yielded early insights regarding the structure and size of particles best suited for the development of a cancer medicine.

In collaboration with scientists at Merck, protein crystal growth research in space gave input regarding the structure and size of particles ideal for developing a new formulation of the company's cancer medicine pembrolizumab for subcutaneous injection.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Health News

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19